ANDA 205085, held by Orient Pharma Co Ltd. Carisoprodol.
As of Nov 16, 2026, ANDA 205085 (Carisoprodol), held by Orient Pharma Co Ltd, was first approved by FDA on Oct 27, 2014, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 27, 2014 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carisoprodol350MG · tablet;oral | Carisoprodol | Rx |
| Apr 27, 2020 | Supplement 3Labeling · Standard review | Approved | None posted |
| Oct 27, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters